GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » Change In Other Working Capital

JWCTF (JW (Cayman) Therapeutics Co) Change In Other Working Capital : $0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is JW (Cayman) Therapeutics Co Change In Other Working Capital?

JW (Cayman) Therapeutics Co's Change In Other Working Capital for the quarter that ended in Dec. 2024 was $0.00 Mil. It means JW (Cayman) Therapeutics Co's Other Working Capital stayed the same from Jun. 2024 to Dec. 2024 .

JW (Cayman) Therapeutics Co's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $-5.90 Mil. It means JW (Cayman) Therapeutics Co's Other Working Capital declined by $5.90 Mil from Dec. 2023 to Dec. 2024 .

JW (Cayman) Therapeutics Co Change In Other Working Capital Historical Data

The historical data trend for JW (Cayman) Therapeutics Co's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW (Cayman) Therapeutics Co Change In Other Working Capital Chart

JW (Cayman) Therapeutics Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Other Working Capital
Get a 7-Day Free Trial -0.88 13.75 -0.04 -1.85 -5.90

JW (Cayman) Therapeutics Co Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

JW (Cayman) Therapeutics Co Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW (Cayman) Therapeutics Co Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of JW (Cayman) Therapeutics Co's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

JW (Cayman) Therapeutics Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » JW (Cayman) Therapeutics Co Ltd (OTCPK:JWCTF) » Definitions » Change In Other Working Capital
Comparable Companies
HKSE:06628 HKSE:02185 HKSE:02496 HKSE:02898 HKSE:09939 HKSE:00690 HKSE:01244 HKSE:02257 HKSE:02197 HKSE:02137 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
02126:Hong Kong
Address
No. 699 Zhong Ke Road, 5th Floor, Building B, Pudong New District, Shanghai, CHN
Website
https://www.jwtherapeutics.com
JW (Cayman) Therapeutics Co Ltd is a clinical-stage cell therapy company in China. It focuses on developing, manufacturing, and commercializing breakthrough cell-based immunotherapies for hematological cancers and solid tumors. Its lead product candidate is relmacabtagene autoleucel, which is a potential superior anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy intended for the treatment of a range of hematological cancers.

JW (Cayman) Therapeutics Co Headlines

No Headlines